An ingredient name can make two offers look alike. Regulatory status, formulation, and the evidence behind the finished medicine can still be very different.
Compounded semaglutide and tirzepatide are not FDA-approved. They should not be described as FDA-approved generics of Wegovy, Ozempic, Zepbound, or Mounjaro.
The quick read
- Compounded preparations are not FDA-approved generics.
- A licensed pharmacy is necessary but does not establish product approval.
- Ask why an approved drug cannot meet your needs.
What approval establishes
FDA approval concerns a specific drug product and its labeled uses. Compounded drugs do not go through the same premarket review for safety, effectiveness, and quality. A pharmacy’s license or a facility’s registration does not turn a compounded preparation into an approved drug.
Why compounding may be considered
FDA says compounded drugs should be used only when a patient’s medical needs cannot be met by an FDA-approved drug. The legal framework also restricts making products that are essentially copies of commercially available medicines. A lower price, a different dose, or adding a vitamin does not automatically establish a permissible patient-specific reason.
Shortage headlines need dates
Both semaglutide and tirzepatide injection shortages were declared resolved, and FDA has published related enforcement policies. The agency has also proposed changes concerning the 503B bulk substances list. A proposal is not a final rule. This site does not determine whether a particular prescription or pharmacy practice complies with every applicable requirement; ask the prescriber and pharmacy for the basis of the specific offer.
Check the pharmacy and the preparation
Get the dispensing pharmacy’s legal name and verify its license with the relevant state regulator. Ask what active ingredient and additives are used. FDA has warned about semaglutide salt forms such as sodium and acetate, fraudulent labels, storage problems, and dosing errors. A certificate or an attractive vial photograph cannot answer every quality question.
Do not transfer clinical-study claims
A study of an approved medicine is evidence about the studied product, population, and treatment conditions. It is not a clinical trial of a telehealth brand’s compounded vial, oral tablet, or added-ingredient formula. Be cautious when a provider uses a branded study’s results beside a different product without making that distinction clear.
A decision checklist
Ask whether an approved option can meet your needs, why a compound is proposed, which licensed pharmacy prepares it, what evidence supports the exact formulation, and how follow-up works. Our provider verification guide and review library help organize the conversation.
Sources & reading notes
Public materials checked September 19, 2026. Provider pages establish advertised terms, not independent proof of outcomes or service quality. Clinical information is general and is not personal medical advice. No clinician review of this article is claimed.